Table 2. Liner regression analysis to identify variables associated with ALC and NLR.
| Variables | B | 95%CI | P value |
|---|---|---|---|
| ALC | |||
| Spleen V5 | −2.307 | −3.931 to −0.682 | 0.006 |
| Spleen V10 | −2.672 | −4.612 to −0.731 | 0.008 |
| Spleen V20 | −2.343 | −5.847 to 1.161 | 0.187 |
| Spleen V30 | −3.192 | −8.580 to 2.196 | 0.242 |
| Mean splenic dose | −6.380 | −13.542 to 0.782 | 0.080 |
| Increase ratio of NLR | |||
| Spleen V5 | 0.022 | 0.004 to 0.041 | 0.019 |
| Spleen V10 | 0.022 | −0.00034 to 0.044 | 0.054 |
| Spleen V20 | 0.002 | −0.038 to 0.042 | 0.915 |
| Spleen V30 | −0.003 | −0.065 to 0.058 | 0.916 |
| Mean splenic dose | 0.045 | −0.036 to 0.127 | 0.274 |
B, region coefficient; CI, confidence interval; V5, volume receiving 5 Gy; V10, volume receiving 10 Gy; V20, volume receiving 20 Gy; V30, volume receiving 30 Gy; ALC, absolute lymphocyte count; NLR, neutrophil/lymphocyte ratio.